Tag Archives: BIO International Convention

What’s really hot in San Diego: Perspective from BIO 2017 Program Chair, Chris LeMasters

chris-lemasters

Meet Chirs LeMasters, 2017 BIO International Convention Program Committee Chair. Chris is the CEO of Promosome LLC a synthetic biology company that was founded by Nobel Laureate Dr. Gerald Edelman, based on his work on mRNA translation at Scripps. He joined the company last year to transition Promosome into a therapeutics company, developing a pipeline of hard-to-express therapeutic proteins. Promosome is also pursuing partnerships with companies developing nucleic acid therapeutics (gene therapy, RNA vaccines, mRNA therapeutics) based Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Shaping the Future of BIO 2017: Tips for Getting the Best Sessions and Speakers on Stage in San Diego

Crowd - Lean in

As the summer begins winding down and the year ahead looms ever closer, it’s time to get ready for BIO 2017! We need your help in shaping the future of the BIO education program. The annual Call for Sessions and Speakers opens September 15 and runs through October 13. Our survey results and event feedback indicate that last year’s program was the best ever with record breaking attendance and the emergence of breakthrough ideas discussed Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Biotech Solutions for Zika

BIO_2016

The Zika virus epidemic continues to rage on. Just today, the WHO advised people in Zika affected countries (much of Latin America and the Caribbean) to consider delaying pregnancy, and emerging evidence suggests a broader range of possible complications for babies born to women infected with the virus than was first thought. Solutions are urgently needed, and biotechnology companies are hard at work to contribute. During a Wednesday at the 2016 BIO International Convention, attendees heard from Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , ,

Strategic Venture Investing by Large Pharma: Is “Smart Money” Right for Your Company

health care, medicine

The strategic venture arms of major biopharma companies like AbbVie, Amgen, Johnson & Johnson and Pfizer offer unique value propositions to early-stage companies and have the flexibility to shape unique deal structures for advancing these partnerships beyond traditional corporate venture capital models. Speakers at a 2016 BIO International Convention panel titled “Strategic Venture Investing by Large Pharma: Is ‘Smart Money’ Right for Your Company?” provided their about how these venture arms fuel innovation in the Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Yoshinori Ohsumi, Ph.D., Receives 2016 Dr. Paul Janssen Award for Biomedical Research

BIO_2016

Johnson & Johnson presented cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology, with the 2016 Dr. Paul Janssen Award for Biomedical Research for his discoveries in autophagy, spanning 27 years. Autophagy, a cell’s “self-eating” mechanism, is necessary for not only recycling nutrients, but for eliminating harmful proteins, organelles and even invasive bacteria. Dr. Ohsumi was honored today during a ceremony at the 2016 BIO International Convention in San Francisco. The award was named for Dr. Paul Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,